Griseofulvin: Microtubule Associated Inhibitor for Antifungal Research

Executive Summary: Griseofulvin is a solid, DMSO-soluble microtubule associated inhibitor with a molecular formula of C17H17ClO6 and a molecular weight of 352.77, demonstrating high purity (≥98%) by HPLC/NMR and optimal storage at -20°C for chemical stability (APExBIO). It selectively disrupts fungal cell mitosis by interfering with microtubule dynamics, supporting advanced antifungal agent research (Bernacki et al., 2019). Benchmarking studies confirm its role as a reference compound for microtubule destabilization and aneugenicity assays. Griseofulvin’s robust DMSO solubility (≥10.45 mg/mL) and validated mechanism enable reproducibility in fungal infection models. This article synthesizes evidence, clarifies boundaries, and provides workflow integration guidance for researchers.

Biological Rationale

Microtubules are essential for the segregation of chromosomes during eukaryotic cell division (Bernacki et al., 2019). Compounds that disrupt microtubule dynamics can induce mitotic arrest and aneuploidy, making them critical tools for dissecting cell division mechanisms. Griseofulvin is a natural antifungal agent that specifically targets fungal microtubules, inhibiting mitosis and limiting the proliferation of pathogenic fungi. Its mechanism is especially relevant for studies on spindle poisons and cellular responses to microtubule disruption (Blebbistatin.com). This action supports its use in antifungal drug research and in modeling fungal infection responses.

Mechanism of Action of Griseofulvin

Griseofulvin acts as a microtubule associated inhibitor by binding to fungal tubulin and disrupting microtubule polymerization (Bernacki et al., 2019). This leads to improper formation of the mitotic spindle, resulting in mitotic arrest and inhibition of fungal cell division. The compound’s activity is specific to fungal, rather than mammalian, microtubules at research concentrations, making it a reference agent for pathway elucidation (Actinomycind.com). Griseofulvin does not directly damage DNA but induces chromosome malsegregation by interfering with spindle assembly and function. Molecular studies classify it as a tubulin destabilizer, distinguishing it from stabilizing agents such as Taxol (Bernacki et al., 2019).

Evidence & Benchmarks

• Griseofulvin is confirmed as a microtubule destabilizer via multi-parametric flow cytometry in TK6 cells, causing a decrease in Taxol-associated fluorescence, indicative of reduced polymerized tubulin (Bernacki et al., 2019, Table 2).
• Exposure of fungal cells to Griseofulvin results in mitotic arrest and subsequent inhibition of cell proliferation without direct DNA damage (Bernacki et al., 2019, Fig. 3).
• High-purity Griseofulvin (≥98%) is validated by HPLC and NMR, supporting its use as a benchmark compound in aneugenicity assays (APExBIO).
• Solubility in DMSO is ≥10.45 mg/mL, enabling preparation of concentrated stock solutions for in vitro and in vivo applications (APExBIO).
• Storage at -20°C maintains chemical integrity and assay reproducibility for at least 12 months (APExBIO).

This article extends prior overviews (e.g., Blebbistatin.com) by providing granular evidence for DMSO solubility and quantifying purity metrics, supporting robust experimental design.

Applications, Limits & Misconceptions

Griseofulvin is primarily used in antifungal agent discovery, functional studies of microtubule dynamics, and as a reference in aneugenicity testing (Actinomycind.com). Its specificity for fungal microtubules makes it valuable for dissecting fungal cell division pathways. The compound is not suitable for direct use in mammalian cell systems for mitotic arrest unless used at much higher, non-selective concentrations.

Common Pitfalls or Misconceptions

• Griseofulvin is not effective as an antibacterial or antiviral agent; its activity is restricted to fungi (Bernacki et al., 2019).
• The compound is not recommended for long-term solution storage; DMSO solutions should be freshly prepared to maintain activity (APExBIO).
• Griseofulvin is for research use only and is not approved for clinical, diagnostic, or veterinary applications (APExBIO).
• It does not induce DNA strand breaks or direct genotoxicity but causes chromosome missegregation via spindle disruption (Bernacki et al., 2019).
• Solubility in ethanol and water is negligible; only DMSO is recommended as a solvent (APExBIO).

This article clarifies and updates prior summaries (e.g., Blebbistatin.com), offering a detailed boundary map for Griseofulvin's research use.

Workflow Integration & Parameters

For optimal results, Griseofulvin should be dissolved in DMSO at concentrations up to 10.45 mg/mL. Prepare stock solutions immediately before use to prevent degradation. Store solid Griseofulvin at -20°C and protect from moisture. APExBIO supplies Griseofulvin as a 10 mM solution in 1 mL DMSO or as a 5 g solid, supporting flexible experimental setups (APExBIO). Shipping is performed on blue ice for small molecules to maintain chemical integrity. Integrate Griseofulvin into antifungal screens, microtubule dynamics assays, and aneugenicity studies as a positive control or mechanistic probe. For related guidance on troubleshooting and advanced workflow parameters, see Actinomycind.com, which this article updates by adding new purity and solubility benchmarks.

Conclusion & Outlook

Griseofulvin remains a gold-standard microtubule associated inhibitor for antifungal drug research and fungal infection model development. Its validated mechanism, quantified purity, and robust workflow parameters support high-content, reproducible studies. Continued integration of Griseofulvin as a reference compound in aneugenicity and mitosis research will facilitate advances in antifungal agent discovery and mechanistic cell biology (Bernacki et al., 2019). For product specifications, ordering, and best-practice usage, refer to the APExBIO Griseofulvin product page (B3680).